Form 4: Director Matthew Lungren Receives RSU Grant at Lumexa

Sentiment:

Statement of Changes in Beneficial Ownership


Director Matthew Lungren was granted 19,358 restricted stock units in Lumexa Imaging Holdings, Inc. on June 10, 2026.

Summary

  • Director Matthew Lungren acquired 19,358 restricted stock units (RSUs) in Lumexa Imaging Holdings, Inc. (LMRI).
  • Each RSU represents a contingent right to receive one share of common stock.
  • The RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders, subject to continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

  • Potential for future dilution of existing shareholders upon the vesting and issuance of the underlying common stock.

Risks

  • Vesting is contingent upon the director's continued service to the company.

Future Outlook

The RSUs are scheduled to vest on the earlier of the one-year anniversary of the grant date (June 10, 2027) or the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practice in the medical imaging and technology sectors to ensure board members maintain a vested interest in company performance.

Comparison to Industry Standards

  • The use of RSUs as a primary vehicle for director compensation is consistent with standard practices for publicly traded companies in the U.S. technology and healthcare sectors.
  • The one-year vesting schedule is aligned with typical market benchmarks for non-employee director equity awards.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of AttorneyDr. Matthew Lungren appointed Paul Gilbert and Ricardo Alvarado as attorneys-in-fact for SEC filing purposes.03/03/2026Standard administrative procedure to ensure timely compliance with SEC reporting requirements.

Stakeholder Impact

  • Shareholders: Minor potential for future dilution.
  • Director: Increased alignment with company performance.

Next Steps

  • Vesting of the 19,358 RSUs on the earlier of June 10, 2027, or the next annual meeting of stockholders.

Key Dates

DateDescription
03/03/2026Date of execution for the Power of Attorney.
06/10/2026Date of the RSU grant transaction.
06/12/2026Date of filing the Form 4.

Keywords

Lumexa Imaging Holdings, LMRI, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.